Sign up to save your podcasts
Or
Share The Body And CBD: FDA updates Congress
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Body And CBD: FDA updates Congress
The FDA has addressed a report to the US House Committee of Appropriations and the US Senate Committee of Appropriations concerning CBD. On today’s show, Tony Frischknecht looks into this report and reflects back on some similar meetings that took place in 2008-2009 about medical cannabis, relating it to the current issue at hand. He highlights the concerns he has about the report, mainly the associated health risks of CBD that were pointed out. He also points out that included in the report is FDA’s willingness to open their doors for discussions. Tread carefully when dealing with the federal government. Learn more about this report for further information.
Love the show? Subscribe, rate, review, and share!
- Here’s How »
Join the Plant Problems Community today:
- blackmarketbook.com
- YouTube
View all episodes
By Tony Frischknecht
5
66 ratings
The FDA has addressed a report to the US House Committee of Appropriations and the US Senate Committee of Appropriations concerning CBD. On today’s show, Tony Frischknecht looks into this report and reflects back on some similar meetings that took place in 2008-2009 about medical cannabis, relating it to the current issue at hand. He highlights the concerns he has about the report, mainly the associated health risks of CBD that were pointed out. He also points out that included in the report is FDA’s willingness to open their doors for discussions. Tread carefully when dealing with the federal government. Learn more about this report for further information.
Love the show? Subscribe, rate, review, and share!
- Here’s How »
Join the Plant Problems Community today:
- blackmarketbook.com
- YouTube